EVA Pharma is participating in WHX Dubai (formerly Arab Health), one of the region’s leading healthcare exhibitions, to share what EVA Pharma has achieved and to discuss what lies ahead for the future of the pharmaceutical field. Let’s shape the future of healthcare together by meeting our team: February 9-12 Stand 31.A56

thumbnail_EVAxWHX-Dubai_Ann_Q10126EVA-Website.png

EVAxWHX-Dubai_Ann_Q10126EVA-Website.png

EVA Pharma is participating in WHX Dubai (formerly Arab Health), one of the region’s leading healthcare exhibitions

WHX Dubai

About EVA Pharma 
EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_EVAxMIS_Ann-01-web-eng (1).png

EVAxMIS_Ann-01-web-eng (1).png

KSA Saudi Made localization Saudization Empowering health 
research and development

Saudi Made 2025

We are thrilled to announce our participation in&nbsp;one of the pharmaceutical industry's most prestigious events,&nbsp;CPHI Middle East 2024!
 
Join us at Riyadh Front Exhibition &amp; Convention Center where EVA Pharma will showcase its dedication to advancing sustainable access to innovative healthcare solutions.
 
Meet our team at booth 2B60 and discover how EVA Pharma is bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

Riyadh Front Exhibition & Convention Center, Saudi Arabia

medium_CPHI_EVAweb 1.png

small_CPHI_EVAweb 1.png

thumbnail_CPHI_EVAweb 1.png

CPHI_EVAweb 1.png

EVA Pharma at CPHI Middle East Riyadh, Saudi Arabia.
Bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

CPHI Middle East 2024

thumbnail_hero-section-ss.jpg

hero-section-ss.jpg

CPHI Worldwide 2025 Frankfurt EVA Pharma is a global healthcare company operating across 70+ countries, dedicated

CPHI Worldwide 2025

Happening at EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our History

Our experienced leadership team keeps us on track.

Meet our Leaders

EVA Pharma’s success is based on its dynamic team, Our people are our power.

Life at EVA Pharma

EVA Pharma is participating in WHX Dubai (formerly Arab Health), one of the region’s leading healthcare exhibitions, to share what EVA Pharma has achieved and to discuss what lies ahead for the future of the pharmaceutical field. Let’s shape the future of healthcare together by meeting our team: February 9-12 Stand 31.A56

thumbnail_Screenshot 2025-10-07 123536.png

Screenshot 2025-10-07 123536.png

EVA Company Profile - 2025.pdf

Company Profile - Global

thumbnail_Screenshot 2025-12-11 150609.png

Screenshot 2025-12-11 150609.png

EVA Company Profile - saudimade SA 2025 Q4-web-Digital.pdf

Company Profile - Saudi Arabia 

thumbnail_Screenshot 2025-06-17 113128.png

Screenshot 2025-06-17 113128.png

EVA Pharma Product Portfolio 2025 Q3.pdf

Product Portfolio

thumbnail_Screenshot 2025-06-17 111006.png

Screenshot 2025-06-17 111006.png

Limitless Narturals Interactive Brochure 2025.pdf

Limitless Naturals Portfolio

thumbnail_CPHI25_webthum_SCMO.png

CPHI25_webthum_SCMO.png

Contract Manufacturing 2025-2026.pdf

Contract Manufacturing

thumbnail_Screenshot 2025-06-17 112622.png

Screenshot 2025-06-17 112622.png

MARC CPHI 2025 digital.pdf

Clinical Research

thumbnail_CPHI25_webthum_Animal-Health-Portfolio.png

CPHI25_webthum_Animal-Health-Portfolio.png

Portfolio Animal health  09 1.pdf

Animal Health Portfolio

thumbnail_Screenshot 2025-10-16 161715.png

Screenshot 2025-10-16 161715.png

EU-Product Portfolio 2025 -2026.pdf

EU- Product Portfolio

Event

EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

EVA Pharma &nbsp;is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_about-section.png

about-section.png

EVA Company Profile - CPHI 2025 Q3 Digital.pdf

Company Profile

EVA Pharma Product Portfolio 2025 Q3 - Frankfurt 1 (2).pdf

Limitless Interactive Brochure 2.pdf

CMO & CDMO Q3 2025 20x25 Digital.pdf

Heading to the 13th Emirates Haematology Conference?
Meet EVA Pharma’s Oncology team at our booth from April 11th to 13th at the Conrad Hotel, Dubai, and explore our latest partnerships and manufacturing advancements aimed at delivering sustainable access to diverse treatment options for oncology patients.
We look forward to impactful conversations with the region’s leading haematology and oncology experts as we find hope, together.

thumbnail__EHCَQ2-2025_website 2.png

_EHCَQ2-2025_website 2.png

EVA Pharma at 13th Emirates Haematology Conference 2025

13th Emirates Haematology Conference 2025

We are excited to connect with delegates spanning the global life science ecosystem at&nbsp;Bio-Europe 2024!
 
Meet our team in Stockholm, Sweden&nbsp;and discover how EVA Pharma is bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

medium_Frame 1.png

small_Frame 1.png

thumbnail_Frame 1.png

Frame 1.png

EVA Pharma at Bio-Europe in Stockholm, Sweden.
Bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

Bio-Europe

large_pexels-kaboompics-com-6335@2x.png

medium_pexels-kaboompics-com-6335@2x.png

small_pexels-kaboompics-com-6335@2x.png

thumbnail_pexels-kaboompics-com-6335@2x.png

pexels-kaboompics-com-6335@2x.png

Are you a Journalist or Media Representative and need information about us? Please feel free to get in touch with our PR Team

Are you a Healthcare professional?

Happening at EVA

09

Event

WHX Dubai

09

Event

15

Event

10

Event

28

Event

Media Contact

Find out more about EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our experienced leadership team keeps us on track.

EVA Pharma’s success is based on its dynamic team, Our people are our power.